APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atazanavir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Atazanavir Market Outlook and Growth Opportunities 2026

20 December 2025198 pages

Choose your research edition.

Industry ResearchAtazanavir Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Atazanavir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Atazanavir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atazanavir Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Atazanavir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Atazanavir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Atazanavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Atazanavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atazanavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Atazanavir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Atazanavir market include TEVA, Mylan, Emcure, Cipla, Bristol-Myers Squibb and Aurobindo Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Atazanavir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Atazanavir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atazanavir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atazanavir market size, projected growth trends, production technologies, key applications, and end-use industries.

Atazanavir Segment by Company

TEVA

Mylan

Emcure

Cipla

Bristol-Myers Squibb

Aurobindo Pharma

Atazanavir Segment by Type

50 mg Oral Powder

300 mg Capsule

200 mg Capsule

150 mg Capsule

Atazanavir Segment by Application

Adults

Children 3 months of age and older

Atazanavir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Atazanavir status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Atazanavir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Atazanavir significant trends, drivers, influence factors in global and regions.

6. To analyze Atazanavir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atazanavir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atazanavir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atazanavir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atazanavir market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Atazanavir industry.

Chapter 3: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Atazanavir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Atazanavir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Atazanavir Industry Trends Table 2. Atazanavir Industry Drivers Table 3. Atazanavir Industry Opportunities and Challenges Table 4. Atazanavir Industry Restraints Table 5. Global Atazanavir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Atazanavir Revenue Share by Company (2021-2026) Table 7. Global Atazanavir Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Atazanavir Sales Volume Share by Company (2021-2026) Table 9. Global Atazanavir Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Atazanavir Company Ranking, (2024-2026) & (USD Million) Table 11. Global Atazanavir Key Company Manufacturing Base & Headquarters Table 12. Global Atazanavir Company, Product Type & Application Table 13. Global Atazanavir Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Atazanavir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50 mg Oral Powder Table 18. Significant Companies of 300 mg Capsule Table 19. Significant Companies of 200 mg Capsule Table 20. Significant Companies of 150 mg Capsule Table 21. Global Atazanavir Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Atazanavir Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Atazanavir Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Atazanavir Sales Volume Share by Type (2021-2026) Table 25. Global Atazanavir Sales Volume Share by Type (2027-2032) Table 26. Global Atazanavir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Atazanavir Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Atazanavir Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Atazanavir Sales Value Share by Type (2021-2026) Table 30. Global Atazanavir Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Adults Table 32. Significant Companies of Children 3 months of age and older Table 33. Global Atazanavir Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Atazanavir Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Atazanavir Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Atazanavir Sales Volume Share by Application (2021-2026) Table 37. Global Atazanavir Sales Volume Share by Application (2027-2032) Table 38. Global Atazanavir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Atazanavir Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Atazanavir Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Atazanavir Sales Value Share by Application (2021-2026) Table 42. Global Atazanavir Sales Value Share by Application (2027-2032) Table 43. Global Atazanavir Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Atazanavir Sales by Region (2021-2026) & (W Units) Table 45. Global Atazanavir Sales Market Share by Region (2021-2026) Table 46. Global Atazanavir Sales by Region (2027-2032) & (W Units) Table 47. Global Atazanavir Sales Market Share by Region (2027-2032) Table 48. Global Atazanavir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Atazanavir Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Atazanavir Sales Value Share by Region (2021-2026) Table 51. Global Atazanavir Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Atazanavir Sales Value Share by Region (2027-2032) Table 53. Global Atazanavir Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Atazanavir Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Atazanavir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Atazanavir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Atazanavir Sales by Country (2021-2026) & (W Units) Table 58. Global Atazanavir Sales Market Share by Country (2021-2026) Table 59. Global Atazanavir Sales by Country (2027-2032) & (W Units) Table 60. Global Atazanavir Sales Market Share by Country (2027-2032) Table 61. Global Atazanavir Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Atazanavir Sales Value Market Share by Country (2021-2026) Table 63. Global Atazanavir Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Atazanavir Sales Value Market Share by Country (2027-2032) Table 65. TEVA Company Information Table 66. TEVA Business Overview Table 67. TEVA Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. TEVA Atazanavir Product Portfolio Table 69. TEVA Recent Development Table 70. Mylan Company Information Table 71. Mylan Business Overview Table 72. Mylan Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Mylan Atazanavir Product Portfolio Table 74. Mylan Recent Development Table 75. Emcure Company Information Table 76. Emcure Business Overview Table 77. Emcure Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Emcure Atazanavir Product Portfolio Table 79. Emcure Recent Development Table 80. Cipla Company Information Table 81. Cipla Business Overview Table 82. Cipla Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Cipla Atazanavir Product Portfolio Table 84. Cipla Recent Development Table 85. Bristol-Myers Squibb Company Information Table 86. Bristol-Myers Squibb Business Overview Table 87. Bristol-Myers Squibb Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Bristol-Myers Squibb Atazanavir Product Portfolio Table 89. Bristol-Myers Squibb Recent Development Table 90. Aurobindo Pharma Company Information Table 91. Aurobindo Pharma Business Overview Table 92. Aurobindo Pharma Atazanavir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Aurobindo Pharma Atazanavir Product Portfolio Table 94. Aurobindo Pharma Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Atazanavir Distributors List Table 98. Atazanavir Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Atazanavir Product Image Figure 2. Global Atazanavir Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atazanavir Sales Value (2021-2032) & (US$ Million) Figure 4. Global Atazanavir Sales (2021-2032) & (W Units) Figure 5. Global Atazanavir Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Atazanavir Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50 mg Oral Powder Image Figure 10. 300 mg Capsule Image Figure 11. 200 mg Capsule Image Figure 12. 150 mg Capsule Image Figure 13. Global Atazanavir Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Atazanavir Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Atazanavir Sales Volume Share by Type (2021-2032) Figure 16. Global Atazanavir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Atazanavir Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Atazanavir Sales Value Share by Type (2021-2032) Figure 19. Adults Image Figure 20. Children 3 months of age and older Image Figure 21. Global Atazanavir Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Atazanavir Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Atazanavir Sales Volume Share by Application (2021-2032) Figure 24. Global Atazanavir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Atazanavir Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Atazanavir Sales Value Share by Application (2021-2032) Figure 27. Global Atazanavir Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Atazanavir Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Atazanavir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Atazanavir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Atazanavir Sales Value (2021-2032) & (US$ Million) Figure 32. North America Atazanavir Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Atazanavir Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Atazanavir Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Atazanavir Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Atazanavir Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Atazanavir Sales Value (2021-2032) & (US$ Million) Figure 38. South America Atazanavir Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Atazanavir Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Atazanavir Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Atazanavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Atazanavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Atazanavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Atazanavir Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Atazanavir Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Oral Powder
  • 300 mg Capsule
  • 200 mg Capsule
  • 150 mg Capsule
Applications
  • Adults
  • Children 3 months of age and older
Companies covered
  • TEVA
  • Mylan
  • Emcure
  • Cipla
  • Bristol-Myers Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atazanavir Sales Value (2021-2032)
  4. 1.2.2 Global Atazanavir Sales Volume (2021-2032)
  5. 1.2.3 Global Atazanavir Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Atazanavir Market Dynamics
  1. 2.1 Atazanavir Industry Trends
  2. 2.2 Atazanavir Industry Drivers
  3. 2.3 Atazanavir Industry Opportunities and Challenges
  4. 2.4 Atazanavir Industry Restraints
3 Atazanavir Market by Company
  1. 3.1 Global Atazanavir Company Revenue Ranking in 2025
  2. 3.2 Global Atazanavir Revenue by Company (2021-2026)
  3. 3.3 Global Atazanavir Sales Volume by Company (2021-2026)
  4. 3.4 Global Atazanavir Average Price by Company (2021-2026)
  5. 3.5 Global Atazanavir Company Ranking (2024-2026)
  6. 3.6 Global Atazanavir Company Manufacturing Base and Headquarters
  7. 3.7 Global Atazanavir Company Product Type and Application
  8. 3.8 Global Atazanavir Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Atazanavir Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Atazanavir Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Atazanavir Market by Type
  1. 4.1 Atazanavir Type Introduction
  2. 4.1.1 50 mg Oral Powder
  3. 4.1.2 300 mg Capsule
  4. 4.1.3 200 mg Capsule
  5. 4.1.4 150 mg Capsule
  6. 4.2 Global Atazanavir Sales Volume by Type
  7. 4.2.1 Global Atazanavir Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Atazanavir Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Atazanavir Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Atazanavir Sales Value by Type
  11. 4.3.1 Global Atazanavir Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Atazanavir Sales Value by Type (2021-2032)
  13. 4.3.3 Global Atazanavir Sales Value Share by Type (2021-2032)
5 Atazanavir Market by Application
  1. 5.1 Atazanavir Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children 3 months of age and older
  4. 5.2 Global Atazanavir Sales Volume by Application
  5. 5.2.1 Global Atazanavir Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Atazanavir Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Atazanavir Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Atazanavir Sales Value by Application
  9. 5.3.1 Global Atazanavir Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Atazanavir Sales Value by Application (2021-2032)
  11. 5.3.3 Global Atazanavir Sales Value Share by Application (2021-2032)
6 Atazanavir Regional Sales and Value Analysis
  1. 6.1 Global Atazanavir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atazanavir Sales by Region (2021-2032)
  3. 6.2.1 Global Atazanavir Sales by Region: 2021-2026
  4. 6.2.2 Global Atazanavir Sales by Region (2027-2032)
  5. 6.3 Global Atazanavir Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Atazanavir Sales Value by Region (2021-2032)
  7. 6.4.1 Global Atazanavir Sales Value by Region: 2021-2026
  8. 6.4.2 Global Atazanavir Sales Value by Region (2027-2032)
  9. 6.5 Global Atazanavir Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Atazanavir Sales Value (2021-2032)
  12. 6.6.2 North America Atazanavir Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Atazanavir Sales Value (2021-2032)
  15. 6.7.2 Europe Atazanavir Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Atazanavir Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Atazanavir Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Atazanavir Sales Value (2021-2032)
  21. 6.9.2 South America Atazanavir Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Atazanavir Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Atazanavir Sales Value Share by Country, 2025 VS 2032
7 Atazanavir Country-level Sales and Value Analysis
  1. 7.1 Global Atazanavir Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Atazanavir Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Atazanavir Sales by Country (2021-2032)
  4. 7.3.1 Global Atazanavir Sales by Country (2021-2026)
  5. 7.3.2 Global Atazanavir Sales by Country (2027-2032)
  6. 7.4 Global Atazanavir Sales Value by Country (2021-2032)
  7. 7.4.1 Global Atazanavir Sales Value by Country (2021-2026)
  8. 7.4.2 Global Atazanavir Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Atazanavir Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Atazanavir Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Atazanavir Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Atazanavir Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Atazanavir Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Atazanavir Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Atazanavir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Atazanavir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Atazanavir Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Atazanavir Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Atazanavir Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Atazanavir Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Atazanavir Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Atazanavir Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Atazanavir Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Atazanavir Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Atazanavir Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Atazanavir Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Atazanavir Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Atazanavir Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Atazanavir Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Atazanavir Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Atazanavir Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Atazanavir Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Atazanavir Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Atazanavir Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Atazanavir Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Atazanavir Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Atazanavir Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Atazanavir Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Atazanavir Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Atazanavir Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Atazanavir Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Atazanavir Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Atazanavir Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Atazanavir Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Atazanavir Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Atazanavir Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Atazanavir Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Atazanavir Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Atazanavir Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Atazanavir Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Atazanavir Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Atazanavir Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Atazanavir Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Atazanavir Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Atazanavir Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Atazanavir Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Atazanavir Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Atazanavir Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Atazanavir Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Atazanavir Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Atazanavir Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Atazanavir Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Atazanavir Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Atazanavir Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Atazanavir Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Atazanavir Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Atazanavir Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Atazanavir Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Atazanavir Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Atazanavir Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Atazanavir Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Atazanavir Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Atazanavir Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Atazanavir Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Atazanavir Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Atazanavir Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Atazanavir Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Atazanavir Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Atazanavir Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Atazanavir Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Atazanavir Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Atazanavir Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Atazanavir Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Atazanavir Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Atazanavir Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Atazanavir Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Atazanavir Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Atazanavir Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Atazanavir Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Atazanavir Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Atazanavir Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Atazanavir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 TEVA
  2. 8.1.1 TEVA Company Information
  3. 8.1.2 TEVA Business Overview
  4. 8.1.3 TEVA Atazanavir Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 TEVA Atazanavir Product Portfolio
  6. 8.1.5 TEVA Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Atazanavir Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Atazanavir Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Emcure
  14. 8.3.1 Emcure Company Information
  15. 8.3.2 Emcure Business Overview
  16. 8.3.3 Emcure Atazanavir Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Emcure Atazanavir Product Portfolio
  18. 8.3.5 Emcure Recent Developments
  19. 8.4 Cipla
  20. 8.4.1 Cipla Company Information
  21. 8.4.2 Cipla Business Overview
  22. 8.4.3 Cipla Atazanavir Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cipla Atazanavir Product Portfolio
  24. 8.4.5 Cipla Recent Developments
  25. 8.5 Bristol-Myers Squibb
  26. 8.5.1 Bristol-Myers Squibb Company Information
  27. 8.5.2 Bristol-Myers Squibb Business Overview
  28. 8.5.3 Bristol-Myers Squibb Atazanavir Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bristol-Myers Squibb Atazanavir Product Portfolio
  30. 8.5.5 Bristol-Myers Squibb Recent Developments
  31. 8.6 Aurobindo Pharma
  32. 8.6.1 Aurobindo Pharma Company Information
  33. 8.6.2 Aurobindo Pharma Business Overview
  34. 8.6.3 Aurobindo Pharma Atazanavir Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurobindo Pharma Atazanavir Product Portfolio
  36. 8.6.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atazanavir Value Chain Analysis
  2. 9.1.1 Atazanavir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atazanavir Sales Mode & Process
  6. 9.2 Atazanavir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atazanavir Distributors
  9. 9.2.3 Atazanavir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst